Literature DB >> 26148490

Clinical Evaluation of Sinonasal Lesions in Patients With Immunoglobulin G4-Related Disease.

Kenichi Takano1, Ayumi Abe2, Ryoto Yajima2, Takuya Kakuki2, Sumito Jitsukawa2, Kazuaki Nomura2, Tetsuo Himi2.   

Abstract

OBJECTIVES: Immunoglobulin G4-related disease (IgG4-RD) is a systemic disease entity characterized by elevated serum IgG4 and extensive IgG4-positive plasma cell infiltration of various organs. Patients with IgG4-RD show nasal manifestations with chronic rhinosinusitis. The objective of this study was to evaluate the clinical characteristics of sinonasal lesions in patients with IgG4-RD.
METHODS: We evaluated radiological findings of sinonasal lesions in 79 patients with IgG4-RD who were divided into 3 groups according to severity. We also compared serological findings, including serum IgG4 and IgE levels, and eosinophil counts.
RESULTS: Rhinosinusitis was found in 41 patients (51.9%). Although there were no significant differences in the serum IgG4 and IgE levels of the groups, there was a significant increase in eosinophil counts (445 ± 311.9/mm³) in Group C. Furthermore, 14 of the 41 patients with rhinosinusitis (34.1%) showed improvement after prednisolone administration. Patients with IgG4-RD and serum eosinophilia tend to also have sinonasal lesions.
CONCLUSIONS: Rhinosinusitis is common in patients with IgG4-RD, and its pathogenesis can be similar to eosinophilic chronic rhinosinusitis.
© The Author(s) 2015.

Entities:  

Keywords:  IgE; IgG4; IgG4-related disease; eosinophil; paranasal sinus; rhinosinusitis

Mesh:

Substances:

Year:  2015        PMID: 26148490     DOI: 10.1177/0003489415593557

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  8 in total

1.  IgG4-related disease: association between chronic rhino-sinusitis and systemic symptoms.

Authors:  Yuan Gao; Ming Zheng; Li Cui; Nan Chen; Yan-Ni Wang; Yu-Tao Zhan; Zhen-Gang Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-06-08       Impact factor: 2.503

2.  IgG4-related disease presenting with destructive sinonasal lesion mimicking malignancy.

Authors:  Bo-Nien Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-07       Impact factor: 2.503

3.  Characteristics of IgG4-related disease complicated with allergic rhinitis or chronic rhinosinusitis: a large cross-sectional cohort study.

Authors:  Qianyu Shi; Xiaoran Ning; Huijuan Li; Xiangbo Ma; Kunkun Wang; Wenjie Bian; Yuxin Zhang; Jiao Xia; Xiaodan Zheng; Yanying Liu; Zhanguo Li
Journal:  Sci Rep       Date:  2022-07-14       Impact factor: 4.996

4.  Identifying clinical subgroups in IgG4-related disease patients using cluster analysis and IgG4-RD composite score.

Authors:  Jieqiong Li; Yu Peng; Yuelun Zhang; Panpan Zhang; Zheng Liu; Hui Lu; Linyi Peng; Liang Zhu; Huadan Xue; Yan Zhao; Xiaofeng Zeng; Yunyun Fei; Wen Zhang
Journal:  Arthritis Res Ther       Date:  2020-01-10       Impact factor: 5.156

5.  Five Cases of IgG4-related Disease with Nasal Mucosa and Sinus Involvement.

Authors:  Masanobu Ueno; Kazuhisa Nakano; Ippei Miyagawa; Yoshiya Tanaka
Journal:  Intern Med       Date:  2020-04-30       Impact factor: 1.271

6.  Clinical features and prognostic factors of ten patients with renal failure caused by IgG4-related retroperitoneal fibrosis.

Authors:  Wei Zhang; Feng Xue; Cui Wang; Leping Shao
Journal:  Oncotarget       Date:  2017-12-07

7.  The Clinicopathologic Spectrum of IgG4-Related Disease

Authors:  Ifeyinwa Emmanuela Obiorah; Alicia Henao Velasquez; Metin Özdemirli
Journal:  Balkan Med J       Date:  2018-06-05       Impact factor: 2.021

8.  Differences and similarities between IgG4-related disease with and without dacryoadenitis and sialoadenitis: clinical manifestations and treatment efficacy.

Authors:  Mu Wang; Panpan Zhang; Wei Lin; Yunyun Fei; Hua Chen; Jing Li; Li Zhang; Wenjie Zheng; Yongze Li; Xiaofeng Zeng; Jiaxin Zhou; Yamin Lai; Xiaowei Liu; Huadan Xue; Yueying Cui; Lian Zhou; Jizhi Zhao; Wen Zhang
Journal:  Arthritis Res Ther       Date:  2019-02-01       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.